Pulmonx Corp reports results for the quarter ended June 30 - Earnings Summary

Pulmonx

29/07/2026 22:51

Pulmonx Corp LUNG.OQ reported a quarterly adjusted loss of 24 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -38 cents.  The mean expectation of five analysts for the quarter was for a loss of 28 cents per share. Wall Street expected results to range from -29 cents to -27 cents per share.
Revenue fell 4.6% to $22.76 million from a year ago; analysts expected $22.40 million. 
Pulmonx Corp's reported EPS for the quarter was a loss of 24 cents​.
The company reported a quarterly loss of $10.08 million.
Pulmonx Corp shares had fallen by 3.8% this quarter and lost 43.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 0.6% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Pulmonx Corp is $3.00, about 58.3% above its last closing price of $1.25
This summary was machine generated from LSEG data July 29 at 09:51 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.28
-0.24
Beat
Mar. 31 2026 
-0.33
-0.33
Met
Dec. 31 2025 
-0.39
-0.25
Beat
Sep. 30 2025 
-0.42
-0.34
Beat